Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Williamson

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Biopharmaceutics & Drug Disposition|March 24, 2021
Blood retinal barrier and ocular pharmacokinetics: Considerations for the development of oncology drugsBeth Williamson, Venkatesh Pilla Reddy
Expert Opinion on Drug Metabolism & Toxicology|November 10, 2017
Hepatic transporter drug-drug interactions: an evaluation of approaches and methodologiesBeth Williamson, Robert J Riley
Biopharmaceutics & Drug Disposition|October 5, 2022
The role of the efflux transporter, P-glycoprotein, at the blood-brain barrier in drug discoveryBenoit Cox, Johan Nicolaï, Beth Williamson
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 28, 2020
Evaluation of the Disconnect between Hepatocyte and Microsome Intrinsic Clearance and In Vitro In Vivo Extrapolation PerformanceBeth Williamson, Stephanie Harlfinger, Dermot F McGinnity
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 19, 2022
Use of selective substrates and inhibitors to rapidly characterise batches of cryopreserved primary human hepatocytes for assessment of active uptake liability in drug discovery and developmentMelanie Golding, Oliver Light, Beth Williamson, et al.
Journal of Pharmaceutical Sciences|November 28, 2020
A Novel Method for Preventing Non-specific Binding in Equilibrium Dialysis Assays Using Solutol® as an AdditiveAbhishek Srivastava, Andy Pike, Beth Williamson, et al.
Journal of Pharmacological and Toxicological Methods|November 7, 2016
Harmonised high throughput microsomal stability assayBeth Williamson, Claire Wilson, Gayle Dagnell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2018
Development and Characterization of a Human Hepatocyte Low Intrinsic Clearance Assay for Use in Drug DiscoveryPaul Lancett, Beth Williamson, Patrick Barton, et al.
Drug Discovery Today|July 22, 2020
Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspectiveAndy Pike, Beth Williamson, Stephanie Harlfinger, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2013
Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentineBeth Williamson, Kelly E Dooley, Yuan Zhang, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Biopharmaceutics & Drug Disposition|March 24, 2021
Blood retinal barrier and ocular pharmacokinetics: Considerations for the development of oncology drugsBeth Williamson, Venkatesh Pilla Reddy
Expert Opinion on Drug Metabolism & Toxicology|November 10, 2017
Hepatic transporter drug-drug interactions: an evaluation of approaches and methodologiesBeth Williamson, Robert J Riley
Biopharmaceutics & Drug Disposition|October 5, 2022
The role of the efflux transporter, P-glycoprotein, at the blood-brain barrier in drug discoveryBenoit Cox, Johan Nicolaï, Beth Williamson
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 28, 2020
Evaluation of the Disconnect between Hepatocyte and Microsome Intrinsic Clearance and In Vitro In Vivo Extrapolation PerformanceBeth Williamson, Stephanie Harlfinger, Dermot F McGinnity
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 19, 2022
Use of selective substrates and inhibitors to rapidly characterise batches of cryopreserved primary human hepatocytes for assessment of active uptake liability in drug discovery and developmentMelanie Golding, Oliver Light, Beth Williamson, et al.
Journal of Pharmaceutical Sciences|November 28, 2020
A Novel Method for Preventing Non-specific Binding in Equilibrium Dialysis Assays Using Solutol® as an AdditiveAbhishek Srivastava, Andy Pike, Beth Williamson, et al.
Journal of Pharmacological and Toxicological Methods|November 7, 2016
Harmonised high throughput microsomal stability assayBeth Williamson, Claire Wilson, Gayle Dagnell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2018
Development and Characterization of a Human Hepatocyte Low Intrinsic Clearance Assay for Use in Drug DiscoveryPaul Lancett, Beth Williamson, Patrick Barton, et al.
Drug Discovery Today|July 22, 2020
Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspectiveAndy Pike, Beth Williamson, Stephanie Harlfinger, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2013
Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentineBeth Williamson, Kelly E Dooley, Yuan Zhang, et al.
Pageof 3